Nippon India Nifty Pharma ETF
Stocks held by month, last 12 months collected. Source: Nippon India Mutual Fund monthly portfolios.
| Stock | Change | Shares before | Shares now | Difference | Value |
|---|---|---|---|---|---|
| SUNPHARMA | Added | 18.09 lakh | 18.41 lakh | +31,424 | ₹365 cr |
| DIVISLAB | Added | 2.17 lakh | 2.21 lakh | +3,766 | ₹209 cr |
| CIPLA | Added | 9.62 lakh | 9.78 lakh | +16,687 | ₹138 cr |
| LAURUSLABS | Added | 6.65 lakh | 6.76 lakh | +11,543 | ₹130 cr |
| TORNTPHARM | Added | 2.51 lakh | 2.55 lakh | +4,371 | ₹129 cr |
| DRREDDY | Added | 10.42 lakh | 10.60 lakh | +18,084 | ₹122 cr |
| LUPIN | Added | 4.15 lakh | 4.22 lakh | +7,190 | ₹92.4 cr |
| AUROPHARMA | Added | 4.73 lakh | 4.81 lakh | +8,196 | ₹82.6 cr |
| GLENMARK | Added | 2.57 lakh | 2.62 lakh | +4,458 | ₹64.9 cr |
| ALKEM | Added | 99,992 | 1.02 lakh | +1,745 | ₹54.2 cr |
| BIOCON | Added | 12.19 lakh | 12.40 lakh | +21,177 | ₹51.1 cr |
| ZYDUSLIFE | Added | 4.27 lakh | 4.35 lakh | +7,444 | ₹50.5 cr |
| IPCALAB | Added | 2.37 lakh | 2.41 lakh | +4,142 | ₹47.7 cr |
| MANKIND | Added | 1.93 lakh | 1.97 lakh | +3,329 | ₹47.6 cr |
| GLAND | Added | 1.36 lakh | 1.39 lakh | +2,345 | ₹40.0 cr |
| SAILIFE | Added | 2.36 lakh | 2.40 lakh | +4,129 | ₹35.0 cr |
| WOCKPHARMA | Added | 1.41 lakh | 1.44 lakh | +2,445 | ₹27.0 cr |
| AJANTPHARM | Added | 71,915 | 73,229 | +1,314 | ₹26.4 cr |
| ABBOTINDIA | Added | 8,906 | 9,055 | +149 | ₹23.4 cr |
| PPLPHARMA | Added | 10.63 lakh | 10.81 lakh | +18,485 | ₹23.2 cr |
Value: this month's market value in the AMC's file (an exit: last month's). "ISIN changed" = a split or bonus between the months; share counts are not comparable across it. Source: Nippon India Mutual Fund monthly portfolios.
| Sector | ||||
|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | Healthcare | 18.41 lakh | ₹365 cr | 20.75% |
| DIVISLAB Divi's Laboratories Limited | Healthcare | 2.21 lakh | ₹209 cr | 11.88% |
| CIPLA Cipla Limited | Healthcare | 9.78 lakh | ₹138 cr | 7.83% |
| LAURUSLABS Laurus Labs Limited | Healthcare | 6.76 lakh | ₹130 cr | 7.36% |
| TORNTPHARM Torrent Pharmaceuticals Limited | Healthcare | 2.55 lakh | ₹129 cr | 7.34% |
| DRREDDY Dr. Reddy's Laboratories Limited | Healthcare | 10.60 lakh | ₹122 cr | 6.95% |
| LUPIN Lupin Limited | Healthcare | 4.22 lakh | ₹92.4 cr | 5.25% |
| AUROPHARMA Aurobindo Pharma Limited | Healthcare | 4.81 lakh | ₹82.6 cr | 4.69% |
| GLENMARK Glenmark Pharmaceuticals Limited | Healthcare | 2.62 lakh | ₹64.9 cr | 3.69% |
| ALKEM Alkem Laboratories Limited | Healthcare | 1.02 lakh | ₹54.2 cr | 3.08% |
| BIOCON Biocon Limited | Healthcare | 12.40 lakh | ₹51.1 cr | 2.90% |
| ZYDUSLIFE Zydus Lifesciences Limited | Healthcare | 4.35 lakh | ₹50.5 cr | 2.87% |
| IPCALAB IPCA Laboratories Limited | Healthcare | 2.41 lakh | ₹47.7 cr | 2.71% |
| MANKIND Mankind Pharma Limited | Healthcare | 1.97 lakh | ₹47.6 cr | 2.70% |
| GLAND Gland Pharma Limited | Healthcare | 1.39 lakh | ₹40.0 cr | 2.27% |
| SAILIFE Sai Life Sciences Limited | Healthcare | 2.40 lakh | ₹35.0 cr | 1.99% |
| WOCKPHARMA Wockhardt Limited | Healthcare | 1.44 lakh | ₹27.0 cr | 1.54% |
| AJANTPHARM Ajanta Pharma Limited | Healthcare | 73,229 | ₹26.4 cr | 1.50% |
| ABBOTINDIA Abbott India Limited | Healthcare | 9,055 | ₹23.4 cr | 1.33% |
| PPLPHARMA Piramal Pharma Limited | Healthcare | 10.81 lakh | ₹23.2 cr | 1.32% |
Equity rows as disclosed, Aug 2026. Source: Nippon India Mutual Fund monthly portfolio.
- Healthcare100.0%
AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels. Source: Nippon India Mutual Fund monthly portfolio; AMFI.
- Large Cap47.8%
- Mid Cap45.1%
- Small Cap7.1%
AMFI's list of Jun 2026. Source: Nippon India Mutual Fund monthly portfolio; AMFI.
| Period | Return | From | To |
|---|---|---|---|
| 1 year | +23.30 % in total | 25 Sep 2025 · NAV ₹22.5191 | 25 Sep 2026 · NAV ₹27.7663 |
| 3 years | +22.07 % a year, compounded | 25 Sep 2023 · NAV ₹15.2552 | 25 Sep 2026 · NAV ₹27.7663 |
| 5 years | +14.11 % a year, compounded | 24 Sep 2021 · NAV ₹14.3400 | 25 Sep 2026 · NAV ₹27.7663 |
| Since first NAV | +13.38 % a year, compounded | 6 Jul 2021 · NAV ₹14.4098 | 25 Sep 2026 · NAV ₹27.7663 |
Past performance may not be sustained in future.
Point-to-point change in the plan's NAV between the two dates shown, as AMFI publishes it; over a year, compounded a year. A period is shown only when a NAV exists within 7 days before its start date. Source: AMFI NAV files (plan code 149008).